Pages that link to "Q43926244"
Jump to navigation
Jump to search
The following pages link to Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation (Q43926244):
Displaying 50 items.
- Regional variation in out-of-hospital cardiac arrest incidence and outcome (Q24635224) (← links)
- Epidemiology of sudden cardiac death: clinical and research implications (Q24650947) (← links)
- Recently published papers: topical issues in pharmacology (Q24798436) (← links)
- Drug therapy in cardiac arrest: a review of the literature (Q26741074) (← links)
- Optimal antiarrhythmic drug therapy for electrical storm (Q27027096) (← links)
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of [...] (Q28087002) (← links)
- The new 2005 resuscitation guidelines of the European Resuscitation Council: comments and supplements (Q28200168) (← links)
- Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation (Q30235184) (← links)
- Role of risk stratification and genetics in sudden cardiac death (Q30240811) (← links)
- In Process Citation (Q30318791) (← links)
- Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations (Q30543305) (← links)
- Efficacy of amiodarone on refractory ventricular fibrillation resistant to lidocaine and cardioversion during weaning from cardiopulmonary bypass in aortic valve replacement for severe aortic stenosis with left ventricular hypertrophy (Q33159016) (← links)
- Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial (Q33583415) (← links)
- Antiarrhythmia drugs for cardiac arrest: a systemic review and meta-analysis (Q33750259) (← links)
- Ventricular tachyarrhythmias (out-of-hospital cardiac arrests) (Q33850518) (← links)
- Tachyarrhythmias, bradyarrhythmias and acute coronary syndromes (Q33909236) (← links)
- Treating critical supraventricular and ventricular arrhythmias (Q33909242) (← links)
- Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats (Q33964046) (← links)
- Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. (Q33968278) (← links)
- Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation (Q34021424) (← links)
- Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. (Q34068720) (← links)
- The Impact of the Code Drugs: Cardioactive Medications in Cardiac Arrest Resuscitation (Q34235195) (← links)
- Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review (Q34371667) (← links)
- Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction (Q34441146) (← links)
- The evaluation and management of electrical storm (Q34736614) (← links)
- A benefit-risk assessment of class III antiarrhythmic agents (Q34871558) (← links)
- Amiodarone: an emergency medicine perspective. (Q35048107) (← links)
- Antiarrhythmic drugs: new agents and evolving concepts (Q35073365) (← links)
- Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation (Q35163114) (← links)
- Pediatric cardiopulmonary-cerebral resuscitation: an overview and future directions (Q35171549) (← links)
- Success changes the problem: why ventricular fibrillation is declining, why pulseless electrical activity is emerging, and what to do about it. (Q35179578) (← links)
- Advances in the acute pharmacologic management of cardiac arrhythmias (Q35198974) (← links)
- Role of amiodarone in the era of the implantable cardioverter defibrillator (Q35209698) (← links)
- Electrical storm: case series and review of management (Q35542037) (← links)
- Investigations into distribution of lidocaine in human autopsy material (Q35548945) (← links)
- New treatments for perioperative cardiac arrhythmias (Q35561204) (← links)
- Community-based responses to impending or actual cardiac arrest and advances in post-cardiac arrest care (Q35566077) (← links)
- Current Pharmacological Advances in the Treatment of Cardiac Arrest (Q35579483) (← links)
- Recent advances in pediatric resuscitation (Q35746787) (← links)
- Amiodarone: a multifaceted antiarrhythmic drug (Q36586992) (← links)
- Pharmacotherapy considerations in advanced cardiac life support (Q36662909) (← links)
- Acute management of sudden cardiac death in adults based upon the new CPR guidelines (Q36708604) (← links)
- A qualitative study of institutional review board members' experience reviewing research proposals using emergency exception from informed consent (Q36807069) (← links)
- Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation (Q36880100) (← links)
- Intravenous amiodarone for acute pharmacological conversion of atrial fibrillation in the emergency department. (Q36885217) (← links)
- Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association (Q37035544) (← links)
- Antiarrhythmic drugs in out-of-hospital cardiac arrest-what does the Amiodarone, Lidocaine, or Placebo Study tell us? (Q37121539) (← links)
- Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (Q37200292) (← links)
- Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction (Q37232553) (← links)
- Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation? (Q37270974) (← links)